Literature DB >> 33488956

Novel Hexahydro-1H-Pyrazino[1,2-a]pyrazine Compounds for Treating Autoimmune Diseases.

Ram W Sabnis1.   

Abstract

Entities:  

Year:  2020        PMID： 33488956      PMCID： PMC7812599          DOI： 10.1021/acsmedchemlett.0c00623

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  6 in total

Review 1.  Polymorphism of toll-like receptor genes and autoimmune endocrine diseases.

Authors:  Kristina A Dvornikova; Elena Y Bystrova; Olga N Platonova; Leonid P Churilov
Journal:  Autoimmun Rev       Date:  2020-02-13       Impact factor: 9.754

Review 2.  Toll-like receptor-induced cytokines as immunotherapeutic targets in cancers and autoimmune diseases.

Authors:  Mahesh Chandra Patra; Masaud Shah; Sangdun Choi
Journal:  Semin Cancer Biol       Date:  2019-05-02       Impact factor: 15.707

Review 3.  Modulation of the Innate Immune Response by Targeting Toll-like Receptors: A Perspective on Their Agonists and Antagonists.

Authors:  Stefano Federico; Luca Pozzetti; Alessandro Papa; Gabriele Carullo; Sandra Gemma; Stefania Butini; Giuseppe Campiani; Nicola Relitti
Journal:  J Med Chem       Date:  2020-09-15       Impact factor: 7.446

Review 4.  Toll-like Receptors and the Control of Immunity.

Authors:  Katherine A Fitzgerald; Jonathan C Kagan
Journal:  Cell       Date:  2020-03-11       Impact factor: 66.850

Review 5.  Toll-like receptors in sepsis-associated cytokine storm and their endogenous negative regulators as future immunomodulatory targets.

Authors:  V Kumar
Journal:  Int Immunopharmacol       Date:  2020-10-12       Impact factor: 4.932

Review 6.  Agonist and antagonist ligands of toll-like receptors 7 and 8: Ingenious tools for therapeutic purposes.

Authors:  Cindy Patinote; Nour Bou Karroum; Georges Moarbess; Natalina Cirnat; Issam Kassab; Pierre-Antoine Bonnet; Carine Deleuze-Masquéfa
Journal:  Eur J Med Chem       Date:  2020-03-17       Impact factor: 6.514
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.